CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Thericon is developing a real-time multispectral imaging platform to assist surgeons in effectively removing cancerous tissue during endoscopic surgery. This technology enhances visual and tactile information, improving the differentiation of tissue types, particularly for bladder cancer applications.
Cancer is the leading cause of death in the EU, with 2.7M diagnoses and 1.3M deaths in 2020.
Effective removal of cancerous tissue through endoscopic surgery is challenging because of limited visual and absent tactile information, along the limitations of current imaging technologies, which make it difficult for surgeons to differentiate between different types of tissue.
For this market, Thericon is developing an rMSI (real-time multispectral imaging) platform providing surgeons with multi-para…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
